IL-10 ͉ TGF- ͉ airway reactivity C D4 ϩ T cells can be subdivided on the basis of their ability to modulate inflammatory responses through production and release of certain cytokines. One subset, with constitutive expression of the low-affinity IL-2 receptor ␣-chain, CD25 (1), has been shown to play prominent roles in dictating the outcome of several diseases (2-11). Th2-like CD4 ϩ T cells producing IL-4, IL-5, and IL-13 play a central role in the pathogenesis of asthma (12)(13)(14). Increased airway hyperresponsiveness (AHR) and inflammation, Th2 cytokines, goblet cell metaplasia, excessive mucus production, elevated antigen-specific IgE, and structural changes in the airways are characteristic of allergic asthma. These changes can be prevented by depletion of CD4 ϩ cells (15,16) or by inhibition and/or alteration of their activities (17, 18). There is increasing evidence for the pivotal role of a subset of CD4 ϩ CD25 ϩ T cells in regulating the development and outcome of atopic allergic diseases in animals (9, 19) and humans (20).The regulatory T cells (Tregs) encompass different subsets that are capable of suppressing cellular immune functions (1, 21-23). CD4 ϩ CD25 ϩ T cells, in both humans and mice, comprise a small fraction (5-10%) (1) of CD4 ϩ T cells produced in the thymus (24-26). They are anergic (27, 28) and express CTLA-4 (CD152) (29), glucocorticoid-induced TNF receptor (30), and the transcription factor Foxp3, which appears to be specific for CD4 ϩ CD25 ϩ regulatory T cells (25,26). They have been shown to suppress allergen-driven T cell activation (9, 31, 32) and regulate Th2 immune responses in humans (33) and animals (34, 35) and modulate both T cell activation and Th2 cytokine skewing (9). Their suppressive activity both in vitro and in vivo appears to be mediated by several mechanisms depending on the model used and includes cell-to-cell contact (27,36,37) and the release of IL-10 (9, 38) and 39,40). A possible mechanism of suppression in humans is the cytolytic activity of CD4 ϩ CD25 ϩ regulatory T cells that are granzyme-and perforin-mediated (41).Although the regulatory profiles of CD4 ϩ CD25 ϩ T cells have been described in mouse models of allergen-induced AHR and airway inflammation (9,34,35), the mechanisms that direct the functional activation of these regulatory activities have not been well defined. In the present study, we investigated the role of MHC I on naturally occurring CD4 ϩ CD25 ϩ regulatory T cells (nTregs) and the requirement for interaction with CD8 in the lung and show that interactions between MHC I and CD8 are essential for the expression of the immunoregulatory properties of nTregs on lung allergic responses.